Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Pinkerton

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
The International Journal on Drug Policy|April 1, 2011
How many HIV infections are prevented by Vancouver Canada's supervised injection facility?Steven D Pinkerton
AIDS (London, England)|July 17, 2007
How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?Steven D Pinkerton
AIDS and Behavior|September 20, 2011
HIV transmission rate modeling: a primer, review, and extensionSteven D Pinkerton
AIDS and Behavior|December 8, 2007
Probability of HIV transmission during acute infection in Rakai, UgandaSteven D Pinkerton
Addiction (Abingdon, England)|July 27, 2010
Is Vancouver Canada's supervised injection facility cost-saving?Steven D Pinkerton
Health Affairs (Project Hope)|April 12, 2012
Multiple drug cost containment policies in Michigan's Medicaid program saved money overall, although some increased costsJennifer Kibicho, Steven D Pinkerton
AIDS and Behavior|June 29, 2006
Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIVCarol L Galletly, Steven D Pinkerton
AIDS and Behavior|November 4, 2006
Reducing HIV transmission risk by increasing serostatus disclosure: a mathematical modeling analysisSteven D Pinkerton, Carol L Galletly
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 11, 2004
Toward rational criminal HIV exposure lawsCarol L Galletly, Steven D Pinkerton
Sexually Transmitted Diseases|May 2, 2002
Using sexually transmitted disease incidence as a surrogate marker for HIV incidence in prevention trials: a modeling studySteven D Pinkerton, Peter M Layde,
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
The International Journal on Drug Policy|April 1, 2011
How many HIV infections are prevented by Vancouver Canada's supervised injection facility?Steven D Pinkerton
AIDS (London, England)|July 17, 2007
How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?Steven D Pinkerton
AIDS and Behavior|September 20, 2011
HIV transmission rate modeling: a primer, review, and extensionSteven D Pinkerton
AIDS and Behavior|December 8, 2007
Probability of HIV transmission during acute infection in Rakai, UgandaSteven D Pinkerton
Addiction (Abingdon, England)|July 27, 2010
Is Vancouver Canada's supervised injection facility cost-saving?Steven D Pinkerton
Health Affairs (Project Hope)|April 12, 2012
Multiple drug cost containment policies in Michigan's Medicaid program saved money overall, although some increased costsJennifer Kibicho, Steven D Pinkerton
AIDS and Behavior|June 29, 2006
Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIVCarol L Galletly, Steven D Pinkerton
AIDS and Behavior|November 4, 2006
Reducing HIV transmission risk by increasing serostatus disclosure: a mathematical modeling analysisSteven D Pinkerton, Carol L Galletly
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 11, 2004
Toward rational criminal HIV exposure lawsCarol L Galletly, Steven D Pinkerton
Sexually Transmitted Diseases|May 2, 2002
Using sexually transmitted disease incidence as a surrogate marker for HIV incidence in prevention trials: a modeling studySteven D Pinkerton, Peter M Layde,
Pageof 7